← SynDRA

BENZONATATE

SynDRA canonical compound SYN0025135 — structure-anchored drug synonym record

All known targets

• SCN5A

Mechanisms of action (all sources)

• Local anesthetic
• SCN5A BLOCKER

Cross-references

• PubChem CID: 7699
• ChEMBL: CHEMBL1374379
• DrugBank: DB00868
• ChEBI: 3032
• KEGG: D00242
• RxNorm: 18993
• Wikipedia: Benzonatate
• TTD: D0Q2ES
• LINCS BRD: BRD-K91699951

Synonyms

• Benzonatato
• NSC-760128
• Tessalon
• Tessalon perles
• Benzonatatum
• Benzononantin
• Benzononatine
• Exangit
• Tesalon
• Tessalin
• Ventussin
• Tessalon Perles
• KM65
• Benzonatato [INN-Spanish]
• Benzonatatum [INN-Latin]
• Tessalon Capsules (TN)
• Tessalon Perles (TN)
• Tessalon-ciba
• Ventussin-loz
• Benzonatate (USP/INN)
• Benzonatate [USAN:INN:BAN];Nonaethyleneglycol monomethyl ether p-n-butylaminobenzoate
• P-butylaminobenzoic acid omega-O-methylnonaethyleneglycol ester
• Polyethyleneglycol-p-n-butylaminobenzoate methyl ester
• P-(n)-Butylaminobenzoesaeure-(nonaaethylenglykol-monomethylaether)-ester
• P-(n)-Butylaminobenzoesaeure-(nonaaethylenglykol-monomethylaether)-ester [German]
• Benzoic acid, 4-(butylamino)-, 2,5,8,11,14,17,20,23,26-nonaoxaoctacos-28-yl ester
• Benzoic acid, 4-(butylamino)-, 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester
• Benzoic acid, 4-(butylamino)-, 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester (9CI)
• Benzoic acid, p-(butylamino)-, 2-(2-(2-(2-(2-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl ester
• 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl p-(butylamino)benzoate
• 2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl 4-(butylamino)benzoate
• 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate
• 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate
• 3,6,9,12,15,18,21,24,27-Nonaoxaoctacos-1-yl 4-(butylamino)benzoate
• 3,6,9,12,15,18,21,24,27-nonaoxaoctacosyl 4-butylaminobenzoate
• 4-(butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester
• 5P4DHS6ENR
• Benzonatate (USP-RS)

Reported adverse events

• Hypersensitivity
• Death
• Nasal congestion
• Pruritus
• Constipation
• Sedation